| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kinase activity | TNIK SLK SPEG PAK5 MINK1 PAK4 DGKB DGKE GCK NME9 GRK1 BLK STK3 STK4 GUCY2C SPHK1 SHPK PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 1.06e-09 | 764 | 121 | 22 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TNIK SLK SPEG PAK5 MINK1 PAK4 DGKB DGKE GCK GRK1 BLK STK3 STK4 GUCY2C SPHK1 SHPK PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 1.62e-09 | 709 | 121 | 21 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TNIK SLK SPEG PAK5 MINK1 PAK4 DGKB DGKE GCK NME9 GRK1 BLK STK3 STK4 GUCY2C SPHK1 SHPK PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 4.36e-08 | 938 | 121 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 BLK STK3 STK4 GUCY2C PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 6.98e-07 | 600 | 121 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.87e-06 | 17 | 121 | 4 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.24e-05 | 24 | 121 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.32e-05 | 363 | 121 | 11 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 STK3 STK4 PAK1 PAK2 PRKD1 | 1.73e-05 | 446 | 121 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.02e-05 | 27 | 121 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.66e-05 | 102 | 121 | 6 | GO:0001540 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 7.26e-05 | 37 | 121 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.76e-04 | 193 | 121 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.00e-04 | 197 | 121 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | CDP phosphatase activity | 2.17e-04 | 4 | 121 | 2 | GO:0036384 | |
| GeneOntologyMolecularFunction | IDP phosphatase activity | 3.60e-04 | 5 | 121 | 2 | GO:1990003 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.95e-04 | 57 | 121 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.48e-04 | 105 | 121 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.81e-04 | 60 | 121 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 5.47e-04 | 305 | 121 | 8 | GO:0019207 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.53e-04 | 65 | 121 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.53e-04 | 65 | 121 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 7.50e-04 | 7 | 121 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 8.62e-04 | 31 | 121 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.86e-04 | 334 | 121 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 9.96e-04 | 8 | 121 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 9.96e-04 | 8 | 121 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.12e-03 | 75 | 121 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.23e-03 | 77 | 121 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 1.28e-03 | 9 | 121 | 2 | GO:0141038 | |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 1.28e-03 | 9 | 121 | 2 | GO:0045134 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.64e-03 | 140 | 121 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 1.93e-03 | 11 | 121 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.96e-03 | 41 | 121 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 2.31e-03 | 12 | 121 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | amide binding | 2.32e-03 | 299 | 121 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.62e-03 | 227 | 121 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | kinase activator activity | 2.85e-03 | 159 | 121 | 5 | GO:0019209 | |
| GeneOntologyMolecularFunction | glutamate binding | 3.16e-03 | 14 | 121 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.22e-03 | 100 | 121 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | peptide binding | 3.27e-03 | 318 | 121 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 3.63e-03 | 15 | 121 | 2 | GO:0005005 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 8.98e-07 | 228 | 120 | 10 | GO:0046777 | |
| GeneOntologyBiologicalProcess | dendrite development | TNIK ITSN1 MINK1 PAK4 RAPGEF4 DPYSL5 FBXW8 SH3GLB1 PAK1 PAK2 EPHA4 | 4.23e-06 | 335 | 120 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | neuron projection development | TNIK FAT4 TOX ITSN1 MINK1 PAK4 RAPGEF4 DPYSL5 APBB1 APBB2 MAPK8IP3 FBXW8 SH3GLB1 HMCN2 SPHK1 PAK1 PAK2 PRKD1 VPS13B EPHA4 CREB3L2 | 1.53e-05 | 1285 | 120 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.72e-05 | 27 | 120 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | TNIK VIL1 TOX APBB1 CORO1B FBXW8 SH3GLB1 SPHK1 PAK1 PRKD1 EPHA4 CREB3L2 | 3.16e-05 | 494 | 120 | 12 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TNIK VIL1 TOX RAPGEF4 DPYSL5 APBB1 CORO1B GRIN2B FBXW8 SH3GLB1 SPHK1 PAK1 PAK2 PRKD1 EPHA4 CREB3L2 | 3.20e-05 | 846 | 120 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | neuron development | TNIK FAT4 TOX ITSN1 MINK1 PAK4 RAPGEF4 DPYSL5 APBB1 APBB2 MAPK8IP3 GRK1 FBXW8 SH3GLB1 HMCN2 SPHK1 PAK1 PAK2 PRKD1 VPS13B EPHA4 CREB3L2 | 3.35e-05 | 1463 | 120 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TNIK VIL1 TOX RAPGEF4 DPYSL5 APBB1 CORO1B GRIN2B FBXW8 SH3GLB1 SPHK1 PAK1 PAK2 PRKD1 EPHA4 CREB3L2 | 4.06e-05 | 863 | 120 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | phosphatidic acid biosynthetic process | 5.56e-05 | 36 | 120 | 4 | GO:0006654 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TNIK TOX RAPGEF4 DPYSL5 APBB1 FBXW8 SH3GLB1 SPHK1 PAK1 PAK2 PRKD1 EPHA4 CREB3L2 | 5.83e-05 | 612 | 120 | 13 | GO:0010975 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TNIK VIL1 MINK1 DPYSL5 APBB1 APBB2 CORO1B SIPA1 MAPK8IP3 GRK1 STK4 CORO1A FBXW8 SH3GLB1 HMCN2 PAK1 PAK2 FMNL1 EPHA4 | 5.88e-05 | 1194 | 120 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 8.47e-05 | 40 | 120 | 4 | GO:1990806 | |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 9.34e-05 | 41 | 120 | 4 | GO:0046473 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 1.25e-04 | 403 | 120 | 10 | GO:1904951 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 2.47e-04 | 150 | 120 | 6 | GO:0050773 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TNIK VIL1 MINK1 DPYSL5 APBB1 APBB2 CORO1B MAPK8IP3 FBXW8 SH3GLB1 HMCN2 PAK1 PAK2 EPHA4 | 2.94e-04 | 819 | 120 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | MAGEA4 HYOU1 ITSN1 PAK5 PAK4 APBB2 GRIA4 MAPK8IP3 GRK1 FAIM CORO1A SH3GLB1 ARL6IP1 SPHK1 PAK2 CABIN1 EPHA4 | 3.00e-04 | 1133 | 120 | 17 | GO:0043066 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TNIK VIL1 MINK1 DPYSL5 APBB1 APBB2 CORO1B MAPK8IP3 FBXW8 SH3GLB1 HMCN2 PAK1 PAK2 EPHA4 | 3.20e-04 | 826 | 120 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of cell differentiation involved in embryonic placenta development | 3.32e-04 | 5 | 120 | 2 | GO:0060800 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | MINK1 SPTBN2 RAPGEF4 DGKB GRIA4 DGKE GRIK4 GRIN2A GRIN2B SLC12A2 SPHK1 PAK1 KCNN1 KMT2A EPHA4 | 3.32e-04 | 931 | 120 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | MINK1 SPTBN2 RAPGEF4 DGKB GRIA4 DGKE GRIK4 GRIN2A GRIN2B SLC12A2 SPHK1 PAK1 KCNN1 KMT2A EPHA4 | 3.32e-04 | 931 | 120 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 3.41e-04 | 103 | 120 | 5 | GO:0048814 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | MINK1 SPTBN2 RAPGEF4 DGKB GRIA4 DGKE GRIK4 GRIN2A GRIN2B SLC12A2 SPHK1 PAK1 KCNN1 KMT2A EPHA4 | 3.64e-04 | 939 | 120 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 3.75e-04 | 300 | 120 | 8 | GO:0110053 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 3.87e-04 | 59 | 120 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 3.92e-04 | 302 | 120 | 8 | GO:0022604 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 4.16e-04 | 384 | 120 | 9 | GO:0032956 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TNIK MINK1 DPYSL5 APBB1 APBB2 MAPK8IP3 GRK1 FBXW8 SH3GLB1 HMCN2 PAK1 PAK2 EPHA4 | 4.18e-04 | 748 | 120 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | MAGEA4 HYOU1 ITSN1 PAK5 PAK4 APBB2 GRIA4 MAPK8IP3 GRK1 FAIM CORO1A SH3GLB1 ARL6IP1 SPHK1 PAK2 CABIN1 EPHA4 | 4.38e-04 | 1171 | 120 | 17 | GO:0043069 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | RAPGEF4 DGKB GRIA4 DGKE GRIK4 GRIN2A GRIN2B SLC12A2 SPHK1 PAK1 KMT2A EPHA4 | 4.90e-04 | 663 | 120 | 12 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | RAPGEF4 DGKB GRIA4 DGKE GRIK4 GRIN2A GRIN2B SLC12A2 SPHK1 PAK1 KMT2A EPHA4 | 4.97e-04 | 664 | 120 | 12 | GO:0099177 |
| GeneOntologyBiologicalProcess | synaptic signaling | MINK1 SPTBN2 RAPGEF4 DGKB GRIA4 DGKE GRIK4 GRIN2A GRIN2B SLC12A2 SPHK1 PAK1 KCNN1 KMT2A EPHA4 | 5.44e-04 | 976 | 120 | 15 | GO:0099536 |
| GeneOntologyBiologicalProcess | protein stabilization | 5.56e-04 | 243 | 120 | 7 | GO:0050821 | |
| GeneOntologyBiologicalProcess | microvillus assembly | 5.66e-04 | 28 | 120 | 3 | GO:0030033 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | SEC16B CCT3 RAPGEF4 APBB1 GCK GRIN2A BLK SH3GLB1 SLC12A2 RPTOR PAK1 PRKD1 | 5.67e-04 | 674 | 120 | 12 | GO:0070201 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | VIL1 SPTBN2 FSD1 CORO1B SPAG5 CORO1A PAK1 KANK4 PAK2 PRKD1 EPHA1 | 5.69e-04 | 579 | 120 | 11 | GO:0051493 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | TNIK VIL1 PAK4 DPYSL5 CORO1B CORO1A FBXW8 SH3GLB1 SLC12A2 SPHK1 PAK1 PAK2 PRKD1 FMNL1 EPHA1 EPHA4 | 5.81e-04 | 1090 | 120 | 16 | GO:0022603 |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 5.99e-04 | 404 | 120 | 9 | GO:1903532 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 6.29e-04 | 67 | 120 | 4 | GO:0050775 | |
| GeneOntologyBiologicalProcess | synapse organization | ITSN1 SPTBN2 RAPGEF4 APBB1 APBB2 DGKB CHD4 GRIN2A GRIN2B HMCN2 PAK1 EPHA4 | 6.54e-04 | 685 | 120 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | VIL1 SEC16B CCT3 RAPGEF4 APBB1 GCK GRIN2A BLK SH3GLB1 PAK1 PRKD1 | 6.74e-04 | 591 | 120 | 11 | GO:1903829 |
| GeneOntologyBiologicalProcess | positive regulation of lamellipodium morphogenesis | 6.92e-04 | 7 | 120 | 2 | GO:2000394 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 7.04e-04 | 69 | 120 | 4 | GO:0010770 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 7.39e-04 | 122 | 120 | 5 | GO:0110020 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 7.67e-04 | 123 | 120 | 5 | GO:0032231 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TNIK VIL1 MINK1 SPTBN2 CORO1B CORO1A PAK1 KANK4 PAK2 PRKD1 FMNL1 CNN3 EPHA1 | 8.09e-04 | 803 | 120 | 13 | GO:0030036 |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 8.42e-04 | 32 | 120 | 3 | GO:0035162 | |
| GeneOntologyBiologicalProcess | glucose 6-phosphate metabolic process | 8.42e-04 | 32 | 120 | 3 | GO:0051156 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 8.42e-04 | 32 | 120 | 3 | GO:0099505 | |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 8.89e-04 | 191 | 120 | 6 | GO:0051017 | |
| GeneOntologyBiologicalProcess | maintenance of lens transparency | 9.19e-04 | 8 | 120 | 2 | GO:0036438 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | TNIK ZNF274 PAK5 MINK1 PAK4 GRIN2B MAPK8IP3 STK3 STK4 SPHK1 PAK1 PAK2 EPHA4 | 9.27e-04 | 815 | 120 | 13 | GO:0043408 |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 9.63e-04 | 194 | 120 | 6 | GO:0051494 | |
| GeneOntologyBiologicalProcess | actin filament bundle organization | 9.89e-04 | 195 | 120 | 6 | GO:0061572 | |
| GeneOntologyBiologicalProcess | microvillus organization | 1.01e-03 | 34 | 120 | 3 | GO:0032528 | |
| GeneOntologyBiologicalProcess | positive regulation of amino acid transport | 1.01e-03 | 34 | 120 | 3 | GO:0051957 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 1.01e-03 | 435 | 120 | 9 | GO:0051047 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 1.04e-03 | 197 | 120 | 6 | GO:1902904 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.05e-03 | 132 | 120 | 5 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 1.06e-03 | 438 | 120 | 9 | GO:0032970 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 1.06e-03 | 438 | 120 | 9 | GO:1902903 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | VIL1 ZNF609 RAPGEF4 MAPK8IP3 STK4 CORO1A DUOX1 SPHK1 PAK1 PRKD1 EPHA1 EPHA4 | 1.07e-03 | 725 | 120 | 12 | GO:2000147 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.07e-03 | 198 | 120 | 6 | GO:0048813 | |
| GeneOntologyCellularComponent | glutamatergic synapse | TNIK ITSN1 SPTBN2 RAPGEF4 DPYSL5 APBB1 DGKB GRIA4 DGKE CHD4 GRIK4 GRIN2A CORO1B GRIN2B CORO1A PAK1 PAK2 CNN3 EPHA4 | 2.33e-07 | 817 | 121 | 19 | GO:0098978 |
| GeneOntologyCellularComponent | cell body | CCT3 ITSN1 SPTBN2 RAPGEF4 DPYSL5 APBB1 IREB2 GRIA4 GRIK4 GRIN2B MAPK8IP3 SH3GLB1 HMCN2 SLC12A2 RPTOR KCNN1 SLC38A7 CNN3 EPHA4 | 1.61e-06 | 929 | 121 | 19 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | ITSN1 SPTBN2 RAPGEF4 DPYSL5 APBB1 IREB2 GRIA4 GRIK4 GRIN2B SH3GLB1 HMCN2 SLC12A2 RPTOR KCNN1 SLC38A7 CNN3 EPHA4 | 6.41e-06 | 835 | 121 | 17 | GO:0043025 |
| GeneOntologyCellularComponent | somatodendritic compartment | ITSN1 MINK1 SPTBN2 RAPGEF4 DPYSL5 APBB1 IREB2 GRIA4 GRIK4 GRIN2A GRIN2B MAPK8IP3 SH3GLB1 HMCN2 SLC12A2 RPTOR PAK1 KCNN1 SLC38A7 CNN3 EPHA4 | 7.17e-06 | 1228 | 121 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | axon | ITSN1 MINK1 RAPGEF4 APBB1 APBB2 IREB2 GRIA4 GRIK4 GRIN2A GRIN2B MAPK8IP3 CORO1A HMCN2 SPHK1 PAK1 SLC38A7 EPHA4 | 1.49e-05 | 891 | 121 | 17 | GO:0030424 |
| GeneOntologyCellularComponent | asymmetric synapse | TNIK MINK1 RAPGEF4 DGKB GRIA4 CHD4 GRIK4 GRIN2A GRIN2B PAK1 PAK2 EPHA4 | 2.14e-05 | 477 | 121 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | distal axon | ITSN1 RAPGEF4 APBB1 APBB2 GRIA4 GRIK4 GRIN2A GRIN2B MAPK8IP3 PAK1 EPHA4 | 4.58e-05 | 435 | 121 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TNIK MINK1 RAPGEF4 DGKB GRIA4 CHD4 GRIK4 GRIN2A GRIN2B PAK1 PAK2 EPHA4 | 5.24e-05 | 523 | 121 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | TNIK MINK1 RAPGEF4 DGKB GRIA4 GRIK4 GRIN2A GRIN2B PAK1 PAK2 EPHA4 | 6.33e-05 | 451 | 121 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | dendritic spine | 8.40e-05 | 242 | 121 | 8 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 9.68e-05 | 247 | 121 | 8 | GO:0044309 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.32e-04 | 45 | 121 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | cell leading edge | VIL1 SLK ITSN1 APBB1 APBB2 GRIN2A CORO1B MAPK8IP3 CORO1A DUOX1 PAK1 | 1.57e-04 | 500 | 121 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | postsynaptic specialization | TNIK MINK1 RAPGEF4 DGKB GRIA4 GRIK4 GRIN2A GRIN2B PAK1 PAK2 EPHA4 | 1.66e-04 | 503 | 121 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.00e-04 | 50 | 121 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | axon terminus | 2.24e-04 | 210 | 121 | 7 | GO:0043679 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.08e-04 | 157 | 121 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | lamellipodium | 3.89e-04 | 230 | 121 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | excitatory synapse | 3.97e-04 | 107 | 121 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | neuron projection terminus | 4.20e-04 | 233 | 121 | 7 | GO:0044306 | |
| GeneOntologyCellularComponent | dendrite | ITSN1 MINK1 RAPGEF4 DPYSL5 APBB1 GRIA4 GRIK4 GRIN2A GRIN2B MAPK8IP3 RPTOR PAK1 CNN3 EPHA4 | 4.46e-04 | 858 | 121 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ITSN1 MINK1 RAPGEF4 DPYSL5 APBB1 GRIA4 GRIK4 GRIN2A GRIN2B MAPK8IP3 RPTOR PAK1 CNN3 EPHA4 | 4.57e-04 | 860 | 121 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 4.91e-04 | 6 | 121 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | postsynapse | TNIK ITSN1 MINK1 SPTBN2 RAPGEF4 APBB1 DGKB GRIA4 GRIK4 GRIN2A GRIN2B PAK1 PAK2 CNN3 EPHA4 | 7.99e-04 | 1018 | 121 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.13e-03 | 201 | 121 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.16e-03 | 277 | 121 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 1.16e-03 | 9 | 121 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | actin filament | 1.61e-03 | 146 | 121 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | presynapse | TNIK ITSN1 SPTBN2 RAPGEF4 APBB1 GRIA4 GRIK4 GRIN2A GRIN2B SH3GLB1 CLCN4 SPHK1 EPHA4 | 1.88e-03 | 886 | 121 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.92e-03 | 576 | 121 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.97e-03 | 43 | 121 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | terminal bouton | 2.35e-03 | 96 | 121 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.87e-03 | 49 | 121 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | growth cone | 3.05e-03 | 245 | 121 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.58e-03 | 253 | 121 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.19e-03 | 56 | 121 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | CHD-type complex | 4.27e-03 | 17 | 121 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 4.27e-03 | 17 | 121 | 2 | GO:0016581 | |
| Domain | PAK_BD | 2.57e-08 | 6 | 122 | 4 | IPR033923 | |
| Domain | Protein_kinase_ATP_BS | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 BLK STK3 STK4 PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 2.65e-08 | 379 | 122 | 15 | IPR017441 |
| Domain | WASP_C | 5.97e-08 | 7 | 122 | 4 | IPR011026 | |
| Domain | Prot_kinase_dom | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 BLK STK3 STK4 GUCY2C PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 1.23e-07 | 489 | 122 | 16 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 BLK STK3 STK4 GUCY2C PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 1.37e-07 | 493 | 122 | 16 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 BLK STK3 STK4 PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 3.19e-07 | 459 | 122 | 15 | PS00107 |
| Domain | Kinase-like_dom | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 BLK STK3 STK4 GUCY2C PAK1 PAK2 PRKD1 EPHA1 EPHA4 | 4.89e-07 | 542 | 122 | 16 | IPR011009 |
| Domain | S_TKc | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 STK3 STK4 PAK1 PAK2 PRKD1 EPHA4 | 6.55e-07 | 359 | 122 | 13 | SM00220 |
| Domain | - | 8.24e-07 | 12 | 122 | 4 | 3.90.810.10 | |
| Domain | Pkinase | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 STK3 STK4 GUCY2C PAK1 PAK2 PRKD1 | 1.28e-06 | 381 | 122 | 13 | PF00069 |
| Domain | PBD | 2.97e-06 | 16 | 122 | 4 | SM00285 | |
| Domain | PBD | 3.86e-06 | 17 | 122 | 4 | PF00786 | |
| Domain | Ser/Thr_kinase_AS | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 STK3 STK4 PAK1 PAK2 PRKD1 | 3.90e-06 | 357 | 122 | 12 | IPR008271 |
| Domain | ANF_lig-bd_rcpt | 4.04e-06 | 37 | 122 | 5 | IPR001828 | |
| Domain | ANF_receptor | 4.04e-06 | 37 | 122 | 5 | PF01094 | |
| Domain | PROTEIN_KINASE_ST | TNIK SLK SPEG PAK5 MINK1 PAK4 GRK1 STK3 STK4 PAK1 PAK2 PRKD1 | 4.49e-06 | 362 | 122 | 12 | PS00108 |
| Domain | Lig_chan-Glu_bd | 4.94e-06 | 18 | 122 | 4 | PF10613 | |
| Domain | Glu/Gly-bd | 4.94e-06 | 18 | 122 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 4.94e-06 | 18 | 122 | 4 | SM00918 | |
| Domain | Iontro_rcpt | 4.94e-06 | 18 | 122 | 4 | IPR001320 | |
| Domain | Iono_rcpt_met | 4.94e-06 | 18 | 122 | 4 | IPR001508 | |
| Domain | Lig_chan | 4.94e-06 | 18 | 122 | 4 | PF00060 | |
| Domain | PBPe | 4.94e-06 | 18 | 122 | 4 | SM00079 | |
| Domain | Peripla_BP_I | 5.28e-06 | 39 | 122 | 5 | IPR028082 | |
| Domain | CRIB | 7.74e-06 | 20 | 122 | 4 | PS50108 | |
| Domain | CRIB_dom | 9.52e-06 | 21 | 122 | 4 | IPR000095 | |
| Domain | Mst1_SARAH_domain | 4.23e-05 | 2 | 122 | 2 | IPR024205 | |
| Domain | Mst1_SARAH | 4.23e-05 | 2 | 122 | 2 | PF11629 | |
| Domain | SNF2_N | 5.41e-05 | 32 | 122 | 4 | IPR000330 | |
| Domain | SNF2_N | 5.41e-05 | 32 | 122 | 4 | PF00176 | |
| Domain | DAGKc | 9.39e-05 | 14 | 122 | 3 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.17e-04 | 15 | 122 | 3 | IPR001206 | |
| Domain | DAGK | 1.17e-04 | 15 | 122 | 3 | PS50146 | |
| Domain | DAGK_cat | 1.17e-04 | 15 | 122 | 3 | PF00781 | |
| Domain | CHD_N | 1.26e-04 | 3 | 122 | 2 | IPR012958 | |
| Domain | CHD_C2 | 1.26e-04 | 3 | 122 | 2 | IPR012957 | |
| Domain | NMDAR2_C | 1.26e-04 | 3 | 122 | 2 | PF10565 | |
| Domain | CHDCT2 | 1.26e-04 | 3 | 122 | 2 | PF08074 | |
| Domain | CHDNT | 1.26e-04 | 3 | 122 | 2 | PF08073 | |
| Domain | DUF1086 | 1.26e-04 | 3 | 122 | 2 | IPR009462 | |
| Domain | DUF1087 | 1.26e-04 | 3 | 122 | 2 | IPR009463 | |
| Domain | NMDAR2_C | 1.26e-04 | 3 | 122 | 2 | IPR018884 | |
| Domain | DUF1087 | 1.26e-04 | 3 | 122 | 2 | PF06465 | |
| Domain | DUF1086 | 1.26e-04 | 3 | 122 | 2 | PF06461 | |
| Domain | DUF1087 | 1.26e-04 | 3 | 122 | 2 | SM01147 | |
| Domain | DUF1086 | 1.26e-04 | 3 | 122 | 2 | SM01146 | |
| Domain | WD40_repeat_dom | 1.46e-04 | 297 | 122 | 9 | IPR017986 | |
| Domain | NAD/diacylglycerol_kinase | 1.73e-04 | 17 | 122 | 3 | IPR016064 | |
| Domain | - | 3.41e-04 | 333 | 122 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.56e-04 | 335 | 122 | 9 | IPR015943 | |
| Domain | WD40 | 3.81e-04 | 268 | 122 | 8 | SM00320 | |
| Domain | WD40_repeat | 4.20e-04 | 272 | 122 | 8 | IPR001680 | |
| Domain | WD_REPEATS_1 | 4.85e-04 | 278 | 122 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.97e-04 | 279 | 122 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.97e-04 | 279 | 122 | 8 | PS50294 | |
| Domain | Haem_d1 | 6.24e-04 | 6 | 122 | 2 | IPR011048 | |
| Domain | WD40_repeat_CS | 7.31e-04 | 164 | 122 | 6 | IPR019775 | |
| Domain | HMG_box_dom | 8.63e-04 | 65 | 122 | 4 | IPR009071 | |
| Domain | Trimer_CC | 8.70e-04 | 7 | 122 | 2 | IPR015049 | |
| Domain | DUF1899 | 8.70e-04 | 7 | 122 | 2 | IPR015048 | |
| Domain | Trimer_CC | 8.70e-04 | 7 | 122 | 2 | PF08954 | |
| Domain | DUF1899 | 8.70e-04 | 7 | 122 | 2 | PF08953 | |
| Domain | Coronin | 8.70e-04 | 7 | 122 | 2 | IPR015505 | |
| Domain | DUF1899 | 8.70e-04 | 7 | 122 | 2 | SM01166 | |
| Domain | GDA1_CD39_NTPase | 1.15e-03 | 8 | 122 | 2 | IPR000407 | |
| Domain | GDA1_CD39 | 1.15e-03 | 8 | 122 | 2 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 1.15e-03 | 8 | 122 | 2 | PS01238 | |
| Domain | SARAH | 1.48e-03 | 9 | 122 | 2 | PS50951 | |
| Domain | SARAH_dom | 1.48e-03 | 9 | 122 | 2 | IPR011524 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.53e-03 | 35 | 122 | 3 | IPR002464 | |
| Domain | WD40 | 1.57e-03 | 259 | 122 | 7 | PF00400 | |
| Domain | DAGK_acc | 1.84e-03 | 10 | 122 | 2 | PF00609 | |
| Domain | HMG_BOX_1 | 1.84e-03 | 10 | 122 | 2 | PS00353 | |
| Domain | Diacylglycerol_kin_accessory | 1.84e-03 | 10 | 122 | 2 | IPR000756 | |
| Domain | DAGKa | 1.84e-03 | 10 | 122 | 2 | SM00045 | |
| Domain | DEAH_ATP_HELICASE | 1.94e-03 | 38 | 122 | 3 | PS00690 | |
| Domain | SPRY | 3.36e-03 | 94 | 122 | 4 | PF00622 | |
| Domain | SPRY_dom | 3.36e-03 | 94 | 122 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 3.49e-03 | 95 | 122 | 4 | IPR001870 | |
| Domain | B302_SPRY | 3.49e-03 | 95 | 122 | 4 | PS50188 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 3.66e-03 | 14 | 122 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 3.66e-03 | 14 | 122 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 3.66e-03 | 14 | 122 | 2 | IPR001426 | |
| Domain | ATPase_dyneun-rel_AAA | 3.66e-03 | 14 | 122 | 2 | IPR011704 | |
| Domain | EphA2_TM | 3.66e-03 | 14 | 122 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 3.66e-03 | 14 | 122 | 2 | IPR001090 | |
| Domain | Eph_TM | 3.66e-03 | 14 | 122 | 2 | IPR027936 | |
| Domain | EPH_lbd | 3.66e-03 | 14 | 122 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 3.66e-03 | 14 | 122 | 2 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 3.66e-03 | 14 | 122 | 2 | IPR016257 | |
| Domain | EPH_LBD | 3.66e-03 | 14 | 122 | 2 | PS51550 | |
| Domain | CNH | 3.66e-03 | 14 | 122 | 2 | SM00036 | |
| Domain | AAA_5 | 3.66e-03 | 14 | 122 | 2 | PF07728 | |
| Domain | PRY | 3.80e-03 | 48 | 122 | 3 | SM00589 | |
| Domain | PRY | 3.80e-03 | 48 | 122 | 3 | IPR006574 | |
| Domain | CNH | 4.20e-03 | 15 | 122 | 2 | PF00780 | |
| Domain | CNH | 4.20e-03 | 15 | 122 | 2 | PS50219 | |
| Domain | CNH_dom | 4.20e-03 | 15 | 122 | 2 | IPR001180 | |
| Domain | Helicase_C | 5.33e-03 | 107 | 122 | 4 | PF00271 | |
| Domain | HELICc | 5.33e-03 | 107 | 122 | 4 | SM00490 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 1.06e-06 | 13 | 90 | 4 | M6322 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 1.18e-05 | 47 | 90 | 5 | M39829 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.82e-05 | 129 | 90 | 7 | M5539 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.63e-05 | 92 | 90 | 6 | M27201 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 5.52e-05 | 33 | 90 | 4 | M6220 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 5.79e-05 | 65 | 90 | 5 | MM14911 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 6.99e-05 | 35 | 90 | 4 | M16801 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 7.83e-05 | 36 | 90 | 4 | MM15603 | |
| Pathway | REACTOME_RHOH_GTPASE_CYCLE | 8.73e-05 | 37 | 90 | 4 | M41813 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 1.19e-04 | 40 | 90 | 4 | M39798 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 1.58e-04 | 43 | 90 | 4 | M39788 | |
| Pathway | WP_RAS_SIGNALING | 1.73e-04 | 184 | 90 | 7 | M39764 | |
| Pathway | SIG_CHEMOTAXIS | 1.89e-04 | 45 | 90 | 4 | M5193 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 1.92e-04 | 18 | 90 | 3 | M48098 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 3.08e-04 | 21 | 90 | 3 | M27736 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.08e-04 | 21 | 90 | 3 | M838 | |
| Pathway | WP_HIPPOYAP_SIGNALING | 3.55e-04 | 22 | 90 | 3 | M39821 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 3.98e-04 | 5 | 90 | 2 | M47667 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 4.67e-04 | 155 | 90 | 6 | M41808 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 5.07e-04 | 58 | 90 | 4 | MM15602 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 5.41e-04 | 59 | 90 | 4 | M41812 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 5.41e-04 | 59 | 90 | 4 | M39750 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 5.52e-04 | 160 | 90 | 6 | MM15990 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 5.95e-04 | 6 | 90 | 2 | M47668 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 6.59e-04 | 27 | 90 | 3 | MM15537 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 8.76e-04 | 67 | 90 | 4 | M295 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 9.02e-04 | 30 | 90 | 3 | M76 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 9.94e-04 | 31 | 90 | 3 | MM1343 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 1.03e-03 | 70 | 90 | 4 | M13266 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.05e-03 | 121 | 90 | 5 | M39823 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.10e-03 | 8 | 90 | 2 | M27737 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.10e-03 | 8 | 90 | 2 | MM15486 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.30e-03 | 34 | 90 | 3 | M177 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.39e-03 | 261 | 90 | 7 | MM15676 | |
| Pubmed | TNIK SLK CCT3 ITSN1 PAK5 MINK1 SPTBN2 RAPGEF4 GRIA4 CHD4 GRIN2A CORO1B GRIN2B SIPA1 MAPK8IP3 UBE2V1 TMEM259 RPTOR PAK1 PAK2 PRKD1 CABIN1 TP53BP1 EPHA4 | 4.01e-14 | 963 | 122 | 24 | 28671696 | |
| Pubmed | Targeted disruption of the gene for the PAK5 kinase in mice. | 2.15e-09 | 6 | 122 | 4 | 14517284 | |
| Pubmed | SLK HYOU1 CCT3 ITSN1 MINK1 SPTBN2 RAPGEF4 DPYSL5 DGKB CHD3 GRIN2A CORO1B GRIN2B SIPA1 MAPK8IP3 STK4 CORO1A NWD2 AFAP1 RPTOR KCTD10 KMT2A | 5.11e-09 | 1431 | 122 | 22 | 37142655 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.10e-08 | 120 | 122 | 8 | 31413325 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK SLK CCT3 PAK4 APBB1 TFIP11 CHD3 CHD4 CORO1B MCCC1 SPAG5 STK4 PAK2 KMT2A SMARCE1 CNN3 TP53BP1 | 3.12e-08 | 934 | 122 | 17 | 33916271 |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 26218748 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 11805089 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 28408623 | ||
| Pubmed | Amyloid-β Receptors: The Good, the Bad, and the Prion Protein. | 1.68e-07 | 4 | 122 | 3 | 26719327 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 10461188 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 26584860 | ||
| Pubmed | 2.76e-07 | 251 | 122 | 9 | 27507650 | ||
| Pubmed | PAK4 DNAH2 DGKB DGKE GCK GRK1 BLK STK3 STK4 SULT1B1 KCTD10 PAK1 PAK2 KMT2A | 3.02e-07 | 730 | 122 | 14 | 34857952 | |
| Pubmed | Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. | 4.19e-07 | 5 | 122 | 3 | 23509247 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 19726645 | ||
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 9160885 | ||
| Pubmed | 1.21e-06 | 23 | 122 | 4 | 30992372 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.45e-06 | 24 | 122 | 4 | 35746896 | |
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 2.33e-06 | 8 | 122 | 3 | 8163463 | |
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 34100982 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TNPO1 ZNF609 PAK4 DPYSL5 DGKE CORO1B SPAG5 STK3 STK4 CORO1A OXA1L SH3GLB1 UBE2V1 RPTOR UQCC1 PRKD1 TP53BP1 | 3.83e-06 | 1321 | 122 | 17 | 27173435 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SLK MED16 PAK5 MINK1 PAK4 CHD4 F13A1 BLK STK3 STK4 SH3GLB1 KMT2A PRKD1 EPHA4 | 3.99e-06 | 910 | 122 | 14 | 36736316 |
| Pubmed | 4.43e-06 | 449 | 122 | 10 | 31732153 | ||
| Pubmed | TNPO1 TNIK HYOU1 VWA8 ITSN1 MINK1 SPTBN2 PAK4 APBB1 DGKE TFIP11 HSPA12B ARL1 OXA1L SLC12A2 DHRS7 VPS13B TP53BP1 | 4.52e-06 | 1487 | 122 | 18 | 33957083 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | CCT3 ITSN1 TFIP11 GRIN2A CORO1B RAD54L2 SIPA1 SPAG5 MAPK8IP3 CORO1A KCNN1 | 4.80e-06 | 560 | 122 | 11 | 21653829 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | TNPO1 ZNF609 MED16 DGKE TFIP11 CHD4 ARL1 OXA1L SLC12A2 ARL6IP1 RPTOR DHRS7 UQCC1 IL17RA ZCCHC7 TP53BP1 | 5.02e-06 | 1203 | 122 | 16 | 29180619 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TNPO1 VWA8 MED16 SPTBN2 DPYSL5 BUD13 TFIP11 CHD4 EHBP1L1 NWD2 AFAP1 OXA1L DHRS7 KCTD10 SMARCE1 | 6.21e-06 | 1082 | 122 | 15 | 38697112 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PAK5 MINK1 PAK4 DPYSL5 APBB1 FSD1 MCCC1 PTPN21 STK3 STK4 SLC12A2 RPTOR KMT2A | 1.10e-05 | 861 | 122 | 13 | 36931259 |
| Pubmed | TNIK VWA8 MINK1 APBB1 GRIA4 GRIN2A CORO1B GRIN2B MCCC1 MAPK8IP3 CORO1A UBE2V1 RPTOR KCTD10 TP53BP1 | 1.14e-05 | 1139 | 122 | 15 | 36417873 | |
| Pubmed | ITSN1 SPTBN2 RAPGEF4 APBB1 APBB2 TFIP11 CHD4 GRIN2B RAD54L2 MAPK8IP3 FAIM PAK1 KCNN1 PAK2 SMARCE1 CABIN1 | 1.14e-05 | 1285 | 122 | 16 | 35914814 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.17e-05 | 13 | 122 | 3 | 20859245 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 1.22e-05 | 2 | 122 | 2 | 7560064 | |
| Pubmed | Activation of PAK1/2 during the shedding of platelet microvesicles. | 1.22e-05 | 2 | 122 | 2 | 20523167 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25131300 | ||
| Pubmed | Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. | 1.22e-05 | 2 | 122 | 2 | 20921396 | |
| Pubmed | Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer. | 1.22e-05 | 2 | 122 | 2 | 34450249 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 35253468 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27199241 | ||
| Pubmed | The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. | 1.22e-05 | 2 | 122 | 2 | 16901514 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25757569 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 38797819 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20696923 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23618906 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19474217 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 38250155 | ||
| Pubmed | p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma. | 1.22e-05 | 2 | 122 | 2 | 33414491 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27734846 | ||
| Pubmed | Importance of the GluN2B carboxy-terminal domain for enhancement of social memories. | 1.22e-05 | 2 | 122 | 2 | 26179233 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26457732 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17442957 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 7575689 | ||
| Pubmed | Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. | 1.22e-05 | 2 | 122 | 2 | 16033900 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15047871 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 38214768 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 36135748 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21503117 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18372311 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25986053 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32247039 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32510157 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19878874 | ||
| Pubmed | Separate functional properties of NMDARs regulate distinct aspects of spatial cognition. | 1.22e-05 | 2 | 122 | 2 | 29764972 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27605622 | ||
| Pubmed | Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function. | 1.22e-05 | 2 | 122 | 2 | 33043365 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 30355491 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11042348 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12127670 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20890276 | ||
| Pubmed | Hippo pathway regulation by cell morphology and stress fibers. | 1.22e-05 | 2 | 122 | 2 | 21831922 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16045501 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 29343826 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32597567 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31391252 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27915379 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32179753 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16944113 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9822733 | ||
| Pubmed | NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. | 1.22e-05 | 2 | 122 | 2 | 15742215 | |
| Pubmed | Protein kinase D regulates cofilin activity through p21-activated kinase 4. | 1.22e-05 | 2 | 122 | 2 | 21832093 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 37657442 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 38813758 | ||
| Pubmed | PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions. | 1.22e-05 | 2 | 122 | 2 | 31748572 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 37153735 | ||
| Pubmed | Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease. | 1.22e-05 | 2 | 122 | 2 | 38731978 | |
| Pubmed | Differential role for PAK1 and PAK4 during the invadopodia lifecycle. | 1.22e-05 | 2 | 122 | 2 | 28301299 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21844203 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19435845 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 30269991 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31498792 | ||
| Pubmed | Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons. | 1.22e-05 | 2 | 122 | 2 | 32191258 | |
| Pubmed | Distinct roles of GRIN2A and GRIN2B variants in neurological conditions. | 1.22e-05 | 2 | 122 | 2 | 31807283 | |
| Pubmed | Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. | 1.22e-05 | 2 | 122 | 2 | 19484742 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26500840 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11964314 | ||
| Pubmed | Effect of Inactivation of Mst1 and Mst2 in the Mouse Adrenal Cortex. | 1.22e-05 | 2 | 122 | 2 | 36405866 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27015584 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19806658 | ||
| Pubmed | STK3/STK4 signalling in adipocytes regulates mitophagy and energy expenditure. | 1.22e-05 | 2 | 122 | 2 | 33758424 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22142193 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 33976221 | ||
| Interaction | SRC interactions | VIL1 TRIM15 FSD1 CHD4 GRIN2A GRIN2B PTPN21 MAPK8IP3 BLK AFAP1 GUCY2C SPHK1 CCNA1 PAK2 KMT2A SMARCE1 PRKD1 EPHA4 | 7.86e-08 | 664 | 120 | 18 | int:SRC |
| Interaction | SHANK3 interactions | TNIK SLK HYOU1 CCT3 ITSN1 SPTBN2 RAPGEF4 TFIP11 GRIN2A GRIN2B SIPA1 SPAG5 MAPK8IP3 | 8.28e-06 | 496 | 120 | 13 | int:SHANK3 |
| Interaction | TNIK interactions | TNIK PAK5 MINK1 SPTBN2 RAPGEF4 GRIN2A GRIN2B HSPA12B SMARCE1 CABIN1 TP53BP1 | 1.76e-05 | 381 | 120 | 11 | int:TNIK |
| Interaction | KCTD13 interactions | SLK HYOU1 CCT3 ITSN1 MINK1 SPTBN2 RAPGEF4 DPYSL5 DGKB CHD3 GRIN2A CORO1B GRIN2B SIPA1 MAPK8IP3 STK4 CORO1A NWD2 AFAP1 RPTOR KCTD10 KMT2A | 2.28e-05 | 1394 | 120 | 22 | int:KCTD13 |
| Interaction | ISX interactions | 3.32e-05 | 31 | 120 | 4 | int:ISX | |
| Cytoband | 12p12 | 5.36e-04 | 13 | 122 | 2 | 12p12 | |
| Cytoband | 5q23.3 | 6.24e-04 | 14 | 122 | 2 | 5q23.3 | |
| Cytoband | 3p21.2 | 1.16e-03 | 19 | 122 | 2 | 3p21.2 | |
| Cytoband | 8q22.2 | 1.71e-03 | 23 | 122 | 2 | 8q22.2 | |
| Cytoband | 3q22.3 | 2.02e-03 | 25 | 122 | 2 | 3q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q23 | 2.90e-03 | 220 | 122 | 4 | chr11q23 | |
| GeneFamily | WD repeat domain containing | 1.06e-04 | 262 | 75 | 7 | 362 | |
| GeneFamily | WD repeat domain containing|Coronins | 3.52e-04 | 7 | 75 | 2 | 495 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 3.52e-04 | 7 | 75 | 2 | 1201 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 7.48e-04 | 10 | 75 | 2 | 1178 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.09e-03 | 12 | 75 | 2 | 1305 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.50e-03 | 14 | 75 | 2 | 1095 | |
| GeneFamily | Heat shock 70kDa proteins | 2.22e-03 | 17 | 75 | 2 | 583 | |
| ToppCell | TCGA-Colorectal|World / Sample_Type by Project: Shred V9 | 3.85e-07 | 166 | 122 | 7 | c018cd8c7a82251c67e3dc812d4d21e527a43456 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-06 | 196 | 122 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-06 | 198 | 122 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-06 | 160 | 122 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-06 | 160 | 122 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.89e-06 | 163 | 122 | 6 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.89e-06 | 163 | 122 | 6 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.00e-06 | 168 | 122 | 6 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.00e-06 | 168 | 122 | 6 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.25e-06 | 169 | 122 | 6 | e68e6c24606fd46eca6f86bb63fa86ea17879ae2 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 7.25e-06 | 169 | 122 | 6 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 176 | 122 | 6 | bfea433544c6d6b8ad55e50ca94c5574460c2e0b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 176 | 122 | 6 | 3c78dee7e1111a579fde6d401b9ecb4d5b8e782f | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-05 | 189 | 122 | 6 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-05 | 195 | 122 | 6 | 6ba23e19801305e071b0e4aaf1ee6f53f3b027d3 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-05 | 195 | 122 | 6 | 7209babdff96c93cd52cfe5d5cfd7e3c0274d8dd | |
| ToppCell | Mild_COVID-19-Myeloid-cDC|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.63e-05 | 195 | 122 | 6 | 24149bb6933135b1a0a5c7f505914942b3782c3a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 198 | 122 | 6 | a183afe4c2034323f77abfa080f359d67da35e8f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-05 | 198 | 122 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 198 | 122 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 200 | 122 | 6 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | Myeloid-E_(Neutrophils)|World / shred on cell class and cell subclass (v4) | 4.97e-05 | 145 | 122 | 5 | 6ae7dbc62116b4d0610fb55703679488e8da4733 | |
| ToppCell | Healthy-B_cell|World / disease group, cell group and cell class | 5.13e-05 | 146 | 122 | 5 | 588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f | |
| ToppCell | Healthy-B_cell|Healthy / disease group, cell group and cell class | 6.41e-05 | 153 | 122 | 5 | 7f82cd61b3f1ebaee3e4bbf68ba858a67c2065e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 155 | 122 | 5 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | IIH-CD8-memory_CD4|IIH / Condition, Cell_class and T cell subcluster | 7.03e-05 | 156 | 122 | 5 | e312fc4317d966fb2b570d1a4a3aa865f781ea93 | |
| ToppCell | facs-Heart-RA-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 163 | 122 | 5 | 13557be854878abc1bcdab909b49b8292d064145 | |
| ToppCell | facs-Heart-RA-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 163 | 122 | 5 | 6c1d1646410e785886d2de103b4b12f73e91edff | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.16e-05 | 165 | 122 | 5 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 167 | 122 | 5 | 2ee1660be117e20f24557522345572d11cbee813 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.69e-05 | 167 | 122 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.69e-05 | 167 | 122 | 5 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 171 | 122 | 5 | e59afa0a773dca3b9c208d17510ea55703b42598 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 171 | 122 | 5 | 4ad28ecfde3d529a09b80be908c446bd5274518e | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 172 | 122 | 5 | 51bea97564a33f0060c546c9be4bf8bf8f1660f6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 172 | 122 | 5 | be4dd4ba8d7a651677c797c25fd75f14e627415a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 175 | 122 | 5 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 176 | 122 | 5 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 177 | 122 | 5 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 177 | 122 | 5 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-04 | 180 | 122 | 5 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 182 | 122 | 5 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 183 | 122 | 5 | cff3197e9ff401362501db2317c86adc6d24b595 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 183 | 122 | 5 | f803dd2881ceaed6327e21a1a51bc3d3ccf4b5f8 | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-04 | 183 | 122 | 5 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 183 | 122 | 5 | 4bd6883daf2dbe8c1b49b776b48d41f9890d1cb4 | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 1.56e-04 | 185 | 122 | 5 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-04 | 187 | 122 | 5 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.64e-04 | 187 | 122 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 187 | 122 | 5 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 187 | 122 | 5 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 187 | 122 | 5 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | droplet-Spleen-SPLEEN-1m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 188 | 122 | 5 | 713fbbd55d2853dee3df2336cada32c153cbd2a1 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 188 | 122 | 5 | 8b1485e63cd4020ba5334a8d4b84725b164549bf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.69e-04 | 188 | 122 | 5 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Neuronal_cells-Schwann_cells|World / Lineage and Cell class | 1.73e-04 | 189 | 122 | 5 | 371cdc92549269e45c23c5a5b3cae9c5d35ee217 | |
| ToppCell | Neuronal_cells|World / Lineage and Cell class | 1.73e-04 | 189 | 122 | 5 | 3948775a0ebd4b32c1623d5487f5581e6e2934d7 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.73e-04 | 189 | 122 | 5 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.73e-04 | 189 | 122 | 5 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 190 | 122 | 5 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.77e-04 | 190 | 122 | 5 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 190 | 122 | 5 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-04 | 191 | 122 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-04 | 191 | 122 | 5 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.81e-04 | 191 | 122 | 5 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 192 | 122 | 5 | 9b8191e66626919cad2c63349c8ef61e9792fcf5 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.86e-04 | 192 | 122 | 5 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-04 | 193 | 122 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 193 | 122 | 5 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 193 | 122 | 5 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 1.90e-04 | 193 | 122 | 5 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-04 | 193 | 122 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 1.90e-04 | 193 | 122 | 5 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-04 | 194 | 122 | 5 | 5afe7f48d3383f3dac18765f97999c8b6936dc1b | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.95e-04 | 194 | 122 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-04 | 194 | 122 | 5 | ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 194 | 122 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.95e-04 | 194 | 122 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-04 | 195 | 122 | 5 | caa3669739974b63470f7e557df96e8d3844dd84 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-04 | 195 | 122 | 5 | 66e5fd9f3208a06d617c5e994822bf57dceae7e2 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-04 | 195 | 122 | 5 | bc5728e9df0b15adec50a7c840ce9f2775135087 | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-04 | 195 | 122 | 5 | 9e5cf33b5dd455efa464a63d7116786c0786aefd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 195 | 122 | 5 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | Macrophages-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.00e-04 | 195 | 122 | 5 | e48bf57e6da23fbb4637a02387155f825455c49f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 196 | 122 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.05e-04 | 196 | 122 | 5 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Dendritic_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.05e-04 | 196 | 122 | 5 | f278b144b8deaee0bf41682081b9fbb0b1e82b19 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-04 | 196 | 122 | 5 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-04 | 197 | 122 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Control-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.09e-04 | 197 | 122 | 5 | b86385c6c1d52ef4e3d855004d77afab61556978 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-04 | 197 | 122 | 5 | 515a2d0ee2bd3fc0a5a0c315e2b0c752e6af7406 | |
| ToppCell | (1)_T_cell-(15)_Treg|(1)_T_cell / shred on Cell_type and subtype | 2.09e-04 | 197 | 122 | 5 | 6e7723e8b977be35c60cc11ac7cfa4f71339441e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-04 | 197 | 122 | 5 | bfa04e5f4156a01df4217b1f59676edb0a7563e1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-04 | 197 | 122 | 5 | 4fccdc69ab4b966de6465f06677435e6f6e6abcd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 197 | 122 | 5 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.09e-04 | 197 | 122 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-04 | 198 | 122 | 5 | 984b3753fabd5553f6f364f90a422b035e421535 | |
| Drug | Norethindrone [68-22-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | ZNF609 MED16 APBB2 PTPN21 RAD54L2 STK3 STK4 CORO1A AFAP1 TMEM259 ENTPD5 | 9.35e-09 | 197 | 122 | 11 | 5055_DN |
| Drug | YM90K | 1.27e-07 | 23 | 122 | 5 | CID005486547 | |
| Drug | gavestinel | 1.98e-07 | 25 | 122 | 5 | CID006450546 | |
| Drug | KN-62 | GRIA4 GRIK4 GRIN2A GRIN2B CLCA1 SPHK1 PAK1 PRKD1 CABIN1 CREB3L2 | 4.67e-07 | 230 | 122 | 10 | CID000003838 |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.09e-06 | 195 | 122 | 9 | 6706_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.14e-06 | 196 | 122 | 9 | 5061_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.19e-06 | 197 | 122 | 9 | 7036_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.24e-06 | 198 | 122 | 9 | 6200_UP | |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; HL60; HT_HG-U133A | 1.29e-06 | 199 | 122 | 9 | 3115_DN | |
| Drug | GAMs | 1.77e-06 | 38 | 122 | 5 | CID000002935 | |
| Drug | IDRA 21 | 3.56e-06 | 20 | 122 | 4 | CID000003688 | |
| Drug | CX546 | 4.38e-06 | 21 | 122 | 4 | CID000002890 | |
| Drug | tetrahydrozoline | 5.17e-06 | 7 | 122 | 3 | CID000005419 | |
| Drug | NS 102 | 5.33e-06 | 22 | 122 | 4 | CID005282252 | |
| Drug | CX516 | 5.33e-06 | 22 | 122 | 4 | CID000148184 | |
| Drug | AC1L1B1W | 6.04e-06 | 84 | 122 | 6 | CID000001248 | |
| Drug | L-CCG-I | 7.11e-06 | 50 | 122 | 5 | CID000001271 | |
| Drug | magnesium | TNPO1 MAN2B2 NTHL1 PAK4 DPYSL5 DGKB GRIA4 DGKE GRIK4 GCK GRIN2A GRIN2B MCCC1 ARL1 GUCY2C SPHK1 ENTPD6 ENTPD5 PRKD1 TNNI1 CABIN1 | 7.14e-06 | 1325 | 122 | 21 | CID000000888 |
| Drug | CGP 39653 | 7.67e-06 | 24 | 122 | 4 | CID006437837 | |
| Drug | LY354740 | 7.85e-06 | 51 | 122 | 5 | CID000114827 | |
| Drug | perzinfotel | 8.24e-06 | 8 | 122 | 3 | CID006918236 | |
| Drug | i 143 | 8.24e-06 | 8 | 122 | 3 | CID002777991 | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.05e-05 | 195 | 122 | 8 | 6614_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.09e-05 | 196 | 122 | 8 | 5102_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.09e-05 | 196 | 122 | 8 | 4539_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.09e-05 | 196 | 122 | 8 | 3095_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 1806_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 4476_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 2654_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 3575_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; PC3; HT_HG-U133A | 1.17e-05 | 198 | 122 | 8 | 4568_DN | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.17e-05 | 198 | 122 | 8 | 6827_DN | |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; PC3; HT_HG-U133A | 1.22e-05 | 199 | 122 | 8 | 5748_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.22e-05 | 199 | 122 | 8 | 2115_UP | |
| Drug | NS3763 | 1.23e-05 | 9 | 122 | 3 | CID004359312 | |
| Drug | L-689,560 | 1.25e-05 | 27 | 122 | 4 | CID000121918 | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.26e-05 | 200 | 122 | 8 | 3991_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.26e-05 | 200 | 122 | 8 | 6334_DN | |
| Drug | C-PP | 1.45e-05 | 28 | 122 | 4 | CID000001228 | |
| Drug | aptiganel | 1.45e-05 | 28 | 122 | 4 | CID000060839 | |
| Drug | glutamate | TNPO1 HYOU1 SPTBN2 AGPAT4 IREB2 GRIA4 GRIK4 GCK GRIN2A GRIN2B MCCC1 CLCA1 CLCN4 ARL6IP1 TRPM8 PRKD1 CABIN1 | 1.50e-05 | 962 | 122 | 17 | CID000000611 |
| Drug | biotinyl-L-lysine | 1.56e-05 | 99 | 122 | 6 | CID000083814 | |
| Drug | MPEP | 1.62e-05 | 59 | 122 | 5 | CID003025961 | |
| Drug | AC1NUW3V | 1.68e-05 | 29 | 122 | 4 | CID005462126 | |
| Drug | ketobemidone | 1.68e-05 | 29 | 122 | 4 | CID000010101 | |
| Drug | nylidrin | 1.75e-05 | 10 | 122 | 3 | CID000004567 | |
| Drug | 3,5-dihydroxyphenylglycine | 1.76e-05 | 60 | 122 | 5 | CID000108001 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 1.93e-05 | 30 | 122 | 4 | CID000001226 | |
| Drug | LY293558 | 1.93e-05 | 30 | 122 | 4 | CID000127894 | |
| Drug | GYKI 53655 | 1.93e-05 | 30 | 122 | 4 | CID000126757 | |
| Drug | AC1L32TU | 1.93e-05 | 30 | 122 | 4 | CID000107831 | |
| Drug | NPC 12626 | 2.21e-05 | 31 | 122 | 4 | CID000108099 | |
| Drug | 4-methylglutamic acid | 2.21e-05 | 31 | 122 | 4 | CID000005365 | |
| Drug | LY235959 | 2.21e-05 | 31 | 122 | 4 | CID000131938 | |
| Drug | eliprodil | 2.21e-05 | 31 | 122 | 4 | CID000060703 | |
| Drug | trans-3,4,5-trihydroxystilbene | GRIA4 GRIK4 GRIN2A GRIN2B SULT1B1 OXA1L GUCY2C SPHK1 CCNA1 PRKD1 IL17RA CABIN1 EPHA4 | 2.37e-05 | 608 | 122 | 13 | CID000005056 |
| Drug | alpha-methyl-4-carboxyphenylglycine | 2.51e-05 | 32 | 122 | 4 | CID000001222 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 2.85e-05 | 33 | 122 | 4 | CID000002071 | |
| Drug | 6,7-dinitroquinoxaline | 2.85e-05 | 33 | 122 | 4 | CID002724608 | |
| Drug | D-CPPene | 3.21e-05 | 34 | 122 | 4 | CID006435801 | |
| Drug | kainite | 3.61e-05 | 35 | 122 | 4 | CID000164810 | |
| Drug | NSC618487 | TNIK SEC16B HYOU1 PAK5 PAK4 APBB2 DGKB DGKE GRIN2A GRIN2B STK4 DUOX1 SPHK1 PRKD1 CABIN1 EPHA4 | 3.91e-05 | 933 | 122 | 16 | CID000005279 |
| Drug | R,S)-AMPA | 4.05e-05 | 36 | 122 | 4 | CID000001221 | |
| Drug | C6H12NO5P | 4.05e-05 | 36 | 122 | 4 | CID000104962 | |
| Drug | gacyclidine | 4.05e-05 | 36 | 122 | 4 | CID000176265 | |
| Drug | glutamic acid diethyl ester | 4.05e-05 | 36 | 122 | 4 | CID000073960 | |
| Drug | gamma-Glu-Gly | 4.52e-05 | 37 | 122 | 4 | CID000100099 | |
| Drug | Nivalenol hydrate | 5.03e-05 | 38 | 122 | 4 | CID000031829 | |
| Drug | L-BMAA | 5.03e-05 | 38 | 122 | 4 | CID000028558 | |
| Drug | CGS 19755 | 5.03e-05 | 38 | 122 | 4 | CID000068736 | |
| Drug | 4CPG | 5.03e-05 | 38 | 122 | 4 | CID000005115 | |
| Drug | ibotenic acid | 5.09e-05 | 122 | 122 | 6 | CID000001233 | |
| Drug | kynurenic acid | 5.09e-05 | 122 | 122 | 6 | CID000003845 | |
| Drug | Methamphetamine | TNPO1 MAGEA4 SLK ZNF609 NTHL1 SPEG ANGEL1 DPYSL5 CHD4 GRIN2A GRIN2B HSPA12B ABCC6 MAPK8IP3 EHBP1L1 TMEM259 TLE3 CCNA1 TNNI1 CABIN1 | 5.39e-05 | 1401 | 122 | 20 | ctd:D008694 |
| Drug | 2-amino-3-phosphonopropionic acid | 5.55e-05 | 76 | 122 | 5 | CID000003857 | |
| Drug | HA-966 | 5.58e-05 | 39 | 122 | 4 | CID000001232 | |
| Drug | DETC-MeSO | 5.58e-05 | 39 | 122 | 4 | CID003035711 | |
| Drug | ginsenoside Rg3 | 6.18e-05 | 40 | 122 | 4 | CID000159727 | |
| Drug | ACEA-1011 | 6.52e-05 | 15 | 122 | 3 | CID000127872 | |
| Drug | thiokynurenic acid | 6.52e-05 | 15 | 122 | 3 | CID003035667 | |
| Drug | 4-AP | 7.72e-05 | 258 | 122 | 8 | CID000001727 | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; PC3; HT_HG-U133A | 7.78e-05 | 191 | 122 | 7 | 6658_DN | |
| Drug | argiopine | 7.99e-05 | 16 | 122 | 3 | CID000122294 | |
| Drug | LY233536 | 7.99e-05 | 16 | 122 | 3 | CID000126239 | |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 8.04e-05 | 192 | 122 | 7 | 2947_DN | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | 8.04e-05 | 192 | 122 | 7 | 1365_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 8.04e-05 | 192 | 122 | 7 | 4151_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 8.04e-05 | 192 | 122 | 7 | 5058_DN | |
| Drug | LY341495 | 8.24e-05 | 43 | 122 | 4 | CID006324636 | |
| Drug | Joro spider toxin | 8.24e-05 | 43 | 122 | 4 | CID000119582 | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A | 8.31e-05 | 193 | 122 | 7 | 3139_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 8.31e-05 | 193 | 122 | 7 | 5088_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 8.31e-05 | 193 | 122 | 7 | 5608_DN | |
| Drug | phorbol 12-myristate | 8.37e-05 | 261 | 122 | 8 | CID000107854 | |
| Drug | conotoxin GV | 8.51e-05 | 3 | 122 | 2 | ctd:C055407 | |
| Drug | Felbamate | 8.51e-05 | 3 | 122 | 2 | DB00949 | |
| Drug | Rp-cAMPS | 8.58e-05 | 194 | 122 | 7 | CID006426631 | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 4331_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 3725_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 4524_DN | |
| Disease | obesity (implicated_via_orthology) | 3.09e-05 | 215 | 121 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | NF-kappa-B essential modulator measurement | 4.99e-05 | 3 | 121 | 2 | EFO_0010597 | |
| Disease | episodic memory | 6.26e-05 | 52 | 121 | 4 | EFO_0004333 | |
| Disease | Metastatic melanoma | 7.26e-05 | 54 | 121 | 4 | C0278883 | |
| Disease | information processing speed, response to cranial radiation therapy | 9.62e-05 | 58 | 121 | 4 | EFO_0004363, EFO_0010950 | |
| Disease | carcinoma (implicated_via_orthology) | 1.41e-04 | 64 | 121 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.04e-04 | 28 | 121 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | entorhinal cortical volume | 2.47e-04 | 6 | 121 | 2 | EFO_0005092 | |
| Disease | schizophrenia (is_implicated_in) | 3.04e-04 | 78 | 121 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | placental insufficiency (biomarker_via_orthology) | 4.59e-04 | 8 | 121 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 4.59e-04 | 8 | 121 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | level of Triacylglycerol (53:4) in blood serum | 4.59e-04 | 8 | 121 | 2 | OBA_2045166 | |
| Disease | epilepsy (implicated_via_orthology) | 5.74e-04 | 163 | 121 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | complement factor D measurement | 5.93e-04 | 93 | 121 | 4 | EFO_0020283 | |
| Disease | suicide behaviour measurement | 7.36e-04 | 43 | 121 | 3 | EFO_0006882 | |
| Disease | sexual dysfunction | 8.95e-04 | 11 | 121 | 2 | EFO_0004714 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 8.95e-04 | 11 | 121 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | vascular dementia (is_marker_for) | 8.95e-04 | 11 | 121 | 2 | DOID:8725 (is_marker_for) | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 8.95e-04 | 11 | 121 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | Schizophrenia | TNIK SPTBN2 GRIA4 CHD4 GRIK4 GRIN2A GRIN2B PTPN21 SLC12A2 PAK2 KMT2A | 1.04e-03 | 883 | 121 | 11 | C0036341 |
| Disease | coronary artery disease | FAT4 SLK DUS4L BUD13 GRIK4 SIPA1 F13A1 MAPK8IP3 STK3 EHBP1L1 RPTOR KCTD10 CABIN1 | 1.26e-03 | 1194 | 121 | 13 | EFO_0001645 |
| Disease | metabolic syndrome | 1.43e-03 | 200 | 121 | 5 | EFO_0000195 | |
| Disease | Maturity onset diabetes mellitus in young | 1.47e-03 | 14 | 121 | 2 | C0342276 | |
| Disease | unipolar depression, response to escitalopram, response to citalopram, mood disorder | 1.69e-03 | 15 | 121 | 2 | EFO_0003761, EFO_0004247, EFO_0006329, EFO_0007871 | |
| Disease | melanoma | 1.83e-03 | 126 | 121 | 4 | EFO_0000756 | |
| Disease | Monogenic diabetes | 1.93e-03 | 16 | 121 | 2 | C3888631 | |
| Disease | brain measurement, neuroimaging measurement | 1.98e-03 | 550 | 121 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.04e-03 | 61 | 121 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.17e-03 | 132 | 121 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | fish consumption measurement | 2.34e-03 | 64 | 121 | 3 | EFO_0010139 | |
| Disease | total blood protein measurement | 2.57e-03 | 449 | 121 | 7 | EFO_0004536 | |
| Disease | opioid dependence | 2.99e-03 | 237 | 121 | 5 | EFO_0005611 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.05e-03 | 145 | 121 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | rosacea severity measurement | 3.20e-03 | 147 | 121 | 4 | EFO_0009180 | |
| Disease | obsolete_red blood cell distribution width | TNPO1 TRIM15 CCT3 ITSN1 BUD13 CHD4 SIPA1 EHBP1L1 SLC12A2 TMEM259 SPHK1 KCTD10 PAK2 | 3.59e-03 | 1347 | 121 | 13 | EFO_0005192 |
| Disease | sleep duration | 3.86e-03 | 362 | 121 | 6 | EFO_0005271 | |
| Disease | Huntington's disease (is_implicated_in) | 3.99e-03 | 23 | 121 | 2 | DOID:12858 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLQGMEAADWTGIGV | 16 | A8MU10 | |
| PAWLMVDTVIGEGEF | 621 | P21709 | |
| FSGRMEVLTDSEGWI | 61 | Q9H3F6 | |
| GKGMRIVDDDVSWTA | 46 | Q9BRD0 | |
| WEMGAVEAISLSILV | 1231 | Q9P2K9 | |
| DIRDTVGIWGEGKDM | 456 | Q92870 | |
| LEASSSEDMGRWIGI | 421 | Q8N556 | |
| SEDMGRWIGILLAET | 426 | Q8N556 | |
| EMTISAIDGGWVART | 3161 | Q6V0I7 | |
| EVIASGSEDCTVMVW | 96 | Q9BR76 | |
| TASLEEQLQGWGEVM | 16 | Q15041 | |
| AVRSLGWVEMTEEEL | 371 | O00213 | |
| TKGTGLDEAMEWLVE | 161 | P40616 | |
| AGTLAGVIDLAVDWM | 81 | P51793 | |
| VIASGSEDCTVMVWE | 96 | P31146 | |
| RAKVMADWVSEGGVL | 386 | Q9Y4B4 | |
| MVVWVTGASSGIGEE | 51 | Q9Y394 | |
| GVLSIWDIDIITAMS | 1296 | Q9ULI1 | |
| LVPGAEEVTMVTWEE | 41 | Q9H0J4 | |
| NWGEDMTSVDAAILI | 421 | Q8TE59 | |
| PVTLDDWGDVDSTMV | 366 | P25092 | |
| ILGWGVGGIETEAVM | 291 | P48200 | |
| VMLVKVGEGEEGQWS | 86 | P35557 | |
| VSEKLVGGMEALEWQ | 636 | Q9NRD9 | |
| GTEVDIWSLGIMVIE | 621 | Q9P286 | |
| EEQAISEAGVMTWVG | 416 | Q96F46 | |
| TSGVGADVARMWEIA | 521 | Q15139 | |
| IMDGSDEGILAWVTV | 166 | O75356 | |
| SASEEEIWEELGVMG | 216 | P43358 | |
| GMGSSDEWSDVQDII | 331 | Q9UPT6 | |
| LSVEWDAMGGKVQDI | 286 | Q9BTV5 | |
| TIWGSNETGEVAVME | 1531 | Q8NDA2 | |
| FGIVVMVTETELSWG | 116 | Q92952 | |
| IASPLEGGWEEVSIM | 46 | P54764 | |
| DADTKIWNGMVGELV | 476 | P48058 | |
| VQMDDWKIVSGGEEG | 481 | Q8N3Y1 | |
| VLRVQEAEAGVWGMS | 931 | Q8N3D4 | |
| MVNAKDDEGVLVGSW | 266 | P00488 | |
| ATMWAVLELGAETGV | 271 | Q15070 | |
| TFLVESGVGELWAEM | 296 | Q96MM6 | |
| MEGWIAVTVSGLVTV | 176 | Q9Y2X0 | |
| GVWLSSEMDAVGLEL | 721 | Q86Y26 | |
| WEQGIAIIAMVTAEE | 986 | Q16825 | |
| DIWSLGIMAIEMIEG | 446 | Q13153 | |
| IWSLGIMAIEMVEGE | 426 | Q13177 | |
| WLEDEGVGATTVMLK | 781 | Q9Y4L1 | |
| EEWVATVTQLLMGIE | 781 | Q9Y6J0 | |
| WAQGTDTILADEMGL | 751 | Q12873 | |
| ADVWSFGVLLMEVVT | 416 | P51451 | |
| IVMVKGEWVDESQTG | 766 | Q15811 | |
| EGMRTILVDWLVEVG | 241 | P78396 | |
| MTDLVAVWDVALSDG | 1 | Q9NVQ4 | |
| DGTVSLEEWIQGGMT | 211 | Q9Y6T7 | |
| VTEMITGTDLVEWQL | 346 | Q96RQ3 | |
| AWEAVEMEIVAGQLV | 646 | Q9Y2E5 | |
| GDLGWMAETAAIITD | 536 | Q4ZIN3 | |
| VDTGGVSRKVAADWM | 91 | O95466 | |
| GIEVNLLGSMESESW | 431 | Q5T7N3 | |
| AENVWEMGGLGILTS | 1411 | Q03164 | |
| ENVWRITGTDGVMVA | 226 | O95620 | |
| LIDGHMEGEIWGLAT | 1681 | Q6ZMW3 | |
| GTVGWVLDAVDDMKI | 281 | P52429 | |
| VEAGIMTATTWLKEG | 716 | Q5T890 | |
| TWTGMVGELIARKAD | 481 | Q16099 | |
| EMIETGIFGELNVWR | 521 | Q15835 | |
| WAQGTDTILADEMGL | 741 | Q14839 | |
| MLVSGLAGEKARWEE | 3281 | Q9P225 | |
| MEVLESGEQGVLQWD | 1 | Q70SY1 | |
| SVIWERGVVGGKMDE | 356 | Q9BPU6 | |
| LVGDELWVVMEFLEG | 386 | O96013 | |
| IWSLGITAIEMAEGA | 216 | Q8N4C8 | |
| EDMTLIGEAISTDIW | 411 | Q86VV8 | |
| TQAVGMWQVLLEDGV | 256 | Q8WZA2 | |
| VEIIEGWVSMGVMAE | 486 | Q96LD4 | |
| EDVGRILGSDTESWM | 326 | Q96R06 | |
| ADVWSLGITLIEMAE | 216 | Q9H2G2 | |
| IGKIIGGMWRDLTDE | 96 | Q969G3 | |
| VSIMNGTDEGVSAWI | 216 | O75354 | |
| DWIIVLANGAIAEMG | 821 | O95255 | |
| MAVAWGTVSGIAVDT | 226 | P78549 | |
| VITVFSVVGMDSDWL | 331 | Q9Y371 | |
| QWMADLGLEVEESTV | 336 | Q9UHJ6 | |
| IMSEAGSGTLEDEWQ | 916 | Q96FS4 | |
| WGGVVTAAMVIALAV | 276 | Q9NVC3 | |
| ETWGVNGETGTLVDM | 476 | P49368 | |
| TTWVSEIIDMILNDG | 51 | O43704 | |
| TTRGAGMVVDWEQET | 1121 | Q8N122 | |
| GMVVDWEQETGLLMS | 1126 | Q8N122 | |
| WEQETGLLMSSGDVR | 1131 | Q8N122 | |
| SLAQMLDEDTVVGVW | 371 | Q969K4 | |
| VQVALVGMEIWSDGD | 261 | O15204 | |
| LLEVEGVEGSMWAAI | 136 | Q9UNK9 | |
| QTVELGSWVGMVTFD | 336 | A8K7I4 | |
| DLRNWIEEVTGMSIG | 31 | Q15417 | |
| GEKVLLTGSVMGTEW | 336 | Q8N7C3 | |
| KMVDDGSGEVQVWRI | 391 | P09327 | |
| VADIWSLGITSIEMA | 201 | Q13188 | |
| LWSLGITAIEMAEGA | 216 | Q9UKE5 | |
| TMLSEAGACGLWVEE | 856 | O15020 | |
| EMVKGEPIGSATDIW | 3131 | Q15772 | |
| DDVVVMATDGLWDVL | 376 | Q96MI6 | |
| EVVALVEGVTWMSEE | 231 | Q96GC6 | |
| VEGVTWMSEEEVLPA | 236 | Q96GC6 | |
| TVVILLGISVAGMEW | 416 | P55011 | |
| GEMGLSAEDGVWAVI | 376 | Q9C019 | |
| GIVWQETEDGMLVVN | 316 | O15014 | |
| GTVSWGLEDDEDMTL | 31 | Q13404 | |
| VEVGDWRKNVEAMSG | 156 | P19237 | |
| ELWSEILMTGGAASV | 1886 | Q12888 | |
| EGFEDVVTTWRTVMG | 236 | Q86XW9 | |
| SMNGEDLLLTGEVSW | 261 | Q9NVA1 | |
| GEVVEEALDVCEMWG | 151 | A6NLC8 | |
| PVEVVDMGGTEDWAL | 481 | Q86VD9 | |
| ATWAIGEISIQMGIE | 736 | Q92973 | |
| TEATGGTVWEEMLQT | 816 | Q96JE7 | |
| GEWLAVGMESSNVEV | 671 | Q04726 | |
| WEQEGTTVEALMMGE | 426 | Q7Z7G8 | |
| TISEGDNVESWMLLG | 166 | Q8N3Z6 | |
| DIWSLGITAIEMAEG | 206 | Q13043 | |
| SEELGRWDALVVMSG | 66 | Q9NYA1 | |
| GVRWMIGVTEIDKGS | 351 | Q9NRZ5 | |
| EENIVAIGIAAWGMV | 206 | Q7Z2W7 | |
| MVLEILDVSGNGWTV | 226 | O60602 | |
| LAEWDKSGVVTVDMG | 1491 | A3KMH1 | |
| VSKIVASMWDGLGEE | 291 | O94900 | |
| WEGMISVSSLVGLLE | 641 | Q9UBB9 | |
| GEMEELETLWLTGIC | 786 | Q12879 | |
| DGEMEELEALWLTGI | 786 | Q13224 |